Australia's most trusted
source of pharma news
Posted 18 October 2024 AM
Treatments for chronic obstructive pulmonary disease (COPD) could soar with the launch of the first national standard of care in response to figures which show that one in 13 Australians over the age of 40 have the condition but only half of them know it.
Developed by the Australian Commission on Safety and Quality in Health Care, the Chronic Obstructive Pulmonary Disease Clinical Care Standard is endorsed by 20 peak bodies, including leading lung health organisations, the Thoracic Society of Australia and New Zealand and Lung Foundation Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.